Opioid use and abuse is a significant social, health and economic issue in Canada. Researchers at the University of Calgary’s Faculty of Veterinary Medicine (UCVM) and Hotchkiss Brain Institute (HBI) at the Cumming School of Medicine (CSM) have discovered that an existing anti-gout medication is effective in reducing the severity of withdrawal symptoms in opioid-dependent rodents.
Researchers at the University of Alberta have developed a new method of controlling biology at the cellular level using light.
Originally published by The Globe and Mail on January 30, 2017 Researchers in Alberta have discovered that a medication once used to treat gout is effective in reducing withdrawal symptoms in opioid-dependent rodents, raising the possibility it could one day do the same for humans. The researchers, from the University Read more…
Drug eases withdrawal symptoms in rodents, human trials next Originally published by CBC News on January 30, 2017 University of Calgary researchers believe a medication already being used to treat gout could be a weapon in the fight against opioid dependency — by alleviating withdrawal symptoms. “It’s quite effective [on Read more…
